Physician

Ralph F. Heaven, M.D.

According to 2025 Medicare claims, Ralph Heaven, M.D. (NPI: 1023056280) practices hematology/oncology in the Abilene, TX market, with the plurality of this provider's patient population coming from Taylor, TX. This provider's primary affiliated billing organization is TEXAS ONCOLOGY PA (NPI: 1811944101; TIN: 752131429) and primary practice location at 79606-5208. Heaven is affiliated with the Caravan Health ACO 43 LLC (ACO ID: A4974) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Heaven's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 576 traditional Medicare patients, billed 152,574 HCPCS/CPT codes, and received $2,186,831 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,562 prescription claims across 200 beneficiaries totaling $1,613,344 in drug costs, led by Brukinsa (Zanubrutinib). DME data shows 64 claims. Open Payments data shows 12 records totaling $986. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,331,507 to $2,186,831. Similarly, Part D prescription costs have moved sharply higher in recent years, from $810,946 to $1,613,344. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $15,337 to $1,821.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.1M$2.2M2015 Medicare payment: $1,331,507 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,250,155 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,105,007 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,164,139 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,519,138 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,741,568 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,691,877 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,188,563 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,696,087 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,186,831 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201548773,039$1,331,507
201666584,110$1,250,155
201773795,043$1,105,007
2018646101,506$1,164,139
2019654128,188$1,519,138
2020649129,258$1,741,568
2021698143,058$1,691,877
2022624162,647$2,188,563
2023570135,423$1,696,087
2024576152,574$2,186,831

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.3M$2.5M2015 Drug cost: $810,946 (USD; Tot_Drug_Cst)2016 Drug cost: $802,255 (USD; Tot_Drug_Cst)2017 Drug cost: $645,230 (USD; Tot_Drug_Cst)2018 Drug cost: $869,391 (USD; Tot_Drug_Cst)2019 Drug cost: $1,103,739 (USD; Tot_Drug_Cst)2020 Drug cost: $1,113,453 (USD; Tot_Drug_Cst)2021 Drug cost: $1,654,506 (USD; Tot_Drug_Cst)2022 Drug cost: $2,535,522 (USD; Tot_Drug_Cst)2023 Drug cost: $1,650,872 (USD; Tot_Drug_Cst)2024 Drug cost: $1,613,344 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151801,728$810,946
20161861,745$802,255
20171771,707$645,230
20181641,598$869,391
20191961,629$1,103,739
20201641,725$1,113,453
20212092,079$1,654,506
20222161,918$2,535,522
20231841,716$1,650,872
20242001,562$1,613,344

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$15K$30K2015 Medicare payment: $30,276 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $28,615 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $29,342 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $4,088 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $3,736 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $7,544 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $8,067 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $1,278 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $534 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $28,586 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
201512209$30,276
201614195$28,615
201716236$29,342
20181598$4,088
20191561$3,736
2020N/R111$7,544
2021N/R133$8,067
2022N/R50$1,278
2023N/R21$534
2024N/R64$28,586

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more251644$88
80053Blood test, comprehensive group of blood chemicals278805$10
36415Insertion of needle into vein for collection of blood sample281952$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count268833$8
83615Lactate dehydrogenase (enzyme) level162329$6

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
BrukinsaZanubrutinib27810$367,229
RevlimidLenalidomide14371$220,098
JakafiRuxolitinib Phosphate12360$207,788
ZarxioFilgrastim-Sndz22640$112,851
Imatinib MesylateImatinib Mesylate11330$45,053

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J8560Etoposide; oral, 50 mgNN/R11$26,810
E1390Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rateYN/R14$950
E0260Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattressYN/R11$407
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodNN/R15$263
K0001Standard wheelchairYN/R13$155

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.12$986Eisai Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ralph F. Heaven, M.D.?

Tedicare shows public-source Medicare data for Ralph F. Heaven, M.D. (NPI 1023056280), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ralph F. Heaven, M.D. have ACO affiliation data?

Ralph F. Heaven, M.D. is shown with ACO affiliation data for Caravan Health ACO 43 LLC (MSSP, ACO ID A4974) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Ralph F. Heaven, M.D.?

Ralph F. Heaven, M.D. is linked to TEXAS ONCOLOGY PA (billing NPI 1811944101) in the available physician profile data.

Does Ralph F. Heaven, M.D. have Open Payments data?

Ralph F. Heaven, M.D. has 12 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.